Ischemic Tissue Articles & Analysis: Older
2 articles found
An Efficient Human Cell–Based Option RepliGut® tissue constructs from Altis Biosystems have the potential to address this critical need in pharmaceutical drug development. ...
Why do we need new cell contenders in the CAR field? Well, different CAR immune cells have different advantages and sometimes unique challenges or limitations. So, we began our discussion of alternative CAR-cell types with CAR-NK cells due to their current standing as the most popular alternative CAR-based therapy. However, the expansion of CARs to other cell types has already begun and ...